Page 106 - GPD-4-2

Gene & Protein in Disease Significance of MXRA7 in bladder cancer

data: the construction of clinical prediction model with R. Pharmacother. 2024;173:116312.
Ann Transl Med. 2019;7(23):796.
doi: 10.1016/j.biopha.2024.116312
doi: 10.21037/atm.2019.12.41
41. Wan X, Wang D, Zhang X, et al. Unleashing the power
38. Harrell FE Jr., Harrell MF Jr., Hmisc D. Package “RMS”. of urine-based biomarkers in diagnosis, prognosis and
United States: Vanderbilt University; 2017. p. 229. monitoring of bladder cancer. Int J Oncol. 2025;66(3):18.
39. Long J, Wang A, Bai Y, et al. Development and validation doi: 10.3892/ijo.2025.5724
of a TP53-associated immune prognostic model for 42. Liu S, Feng C, Tan L, et al. Single-cell dissection of multifocal
hepatocellular carcinoma. EBioMedicine. 2019;42:363-374.
bladder cancer reveals malignant and immune cells variation
doi: 10.1016/j.ebiom.2019.03.021 between primary and recurrent tumor lesions. Commun
Biol. 2024;7(1):1659.
40. Fan J, Chen B, Luo Q, et al. Potential molecular biomarkers
for the diagnosis and prognosis of bladder cancer. Biomed doi: 10.1038/s42003-024-07343-7

Volume 4 Issue 2 (2025) 11 doi: 10.36922/gpd.6256